Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction.

Pubmed ID: 24216124

Pubmed Central ID: PMC3915785

Journal: The American journal of cardiology

Publication Date: Jan. 1, 2014

Affiliation: Department of Internal Medicine, Yale University, New Haven, Connecticut; Program of Applied Translational Research, Yale University, New Haven, Connecticut; Veterans Affairs Health Care System, West Haven, Connecticut.

MeSH Terms: Humans, Male, Adult, Female, Aged, Aged, 80 and over, Risk Factors, United States, Aging, Middle Aged, Prospective Studies, Prognosis, Follow-Up Studies, Creatinine, Survival Rate, Double-Blind Method, Renal Insufficiency, Glomerular Filtration Rate, Ventricular Dysfunction, Left

Grants: K23 HL114868, K24 DK090203, L30 HL115790, T32 HL007891

Authors: Testani JM, Brisco MA, Han G, Laur O, Kula AJ, Cheng SJ, Tang WH, Parikh CR

Cite As: Testani JM, Brisco MA, Han G, Laur O, Kula AJ, Cheng SJ, Tang WH, Parikh CR. Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction. Am J Cardiol 2014 Jan 1;113(1):127-31. Epub 2013 Oct 3.

Studies:

Abstract

Normal aging results in a predictable decrease in glomerular filtration rate (GFR), and low GFR is associated with worsened survival. If this survival disadvantage is directly caused by the low GFR, as opposed to the disease causing the low GFR, the risk should be similar regardless of the underlying mechanism. Our objective was to determine if age-related decreases in estimated GFR (eGFR) carry the same prognostic importance as disease-attributable losses in patients with ventricular dysfunction. We analyzed the Studies Of Left Ventricular Dysfunction limited data set (n = 6,337). The primary analysis focused on determining if the eGFR-mortality relation differed by the extent to which the eGFR was consistent with normal aging. Mean eGFR was 65.7 ml/min/1.73 m(2) (SD = 19.0). Across the range of age in the population (27 to 80 years), baseline eGFR decreased by 0.67 ml/min/1.73 m(2)/year (95% confidence interval [CI] 0.63 to 0.71). The risk of death associated with eGFR was strongly modified by the degree to which the low eGFR could be explained by aging (p for interaction <0.0001). For example, in a model incorporating the interaction, uncorrected eGFR was no longer significantly related to mortality (adjusted hazard ratio 1.0 per 10 ml/min/1.73 m(2), 95% CI 0.97 to 1.1, p = 0.53), whereas a disease-attributable decrease in eGFR above the median carried significant risk (adjusted hazard ratio 2.8, 95% CI 1.6 to 4.7, p <0.001). In conclusion, in the setting of left ventricular dysfunction, renal dysfunction attributable to normal aging had a limited risk for mortality, suggesting that the mechanism underlying renal dysfunction is critical in determining prognosis.